Terms: = Gastric cancer AND MECOM, MDS1-EVI1, EVI1, 2122, ENSG00000085276, Q03112, PRDM3 AND Prognosis
5 results:
1. Management of type 1 gastric neuroendocrine tumors: an 11-year retrospective single-center study.
Chen YY; Guo WJ; Shi YF; Su F; Yu FH; Chen RA; Wang C; Liu JX; Luo J; Tan HY
BMC Gastroenterol; 2023 Dec; 23(1):440. PubMed ID: 38097952
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological Features and prognosis of Gastrointestinal Metastases From Breast Carcinoma: A Clinicopathological Study of 22 Patients.
Wang S; Li W; Li S; Liu X; Zhang L; Hao C; Meng W; Zhao W; Tong Z
Int J Surg Pathol; 2023 Sep; 31(6):1075-1084. PubMed ID: 36803140
[No Abstract] [Full Text] [Related]
3. Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma.
Hao D; He S; Harada K; Pizzi MP; Lu Y; Guan P; Chen L; Wang R; Zhang S; Sewastjanow-Silva M; Abdelhakeem A; Shanbhag N; Bhutani M; Han G; Lee JH; Zhao S; Weston B; Blum Murphy M; Waters R; Estrella JS; Roy-Chowdhuri S; Gan Q; Lee JS; Peng G; Hanash SM; Calin GA; Song X; Zhang J; Song S; Wang L; Ajani JA
Gut; 2021 Nov; 70(11):2055-2065. PubMed ID: 33334899
[TBL] [Abstract] [Full Text] [Related]
4. FOXO4 and FOXD3 are predictive of prognosis in gastric carcinoma patients.
Li J; Jiang Z; Han F; Liu S; Yuan X; Tong J
Oncotarget; 2016 May; 7(18):25585-92. PubMed ID: 27027443
[TBL] [Abstract] [Full Text] [Related]
5. SKI and MEL1 cooperate to inhibit transforming growth factor-beta signal in gastric cancer cells.
Takahata M; Inoue Y; Tsuda H; Imoto I; Koinuma D; Hayashi M; Ichikura T; Yamori T; Nagasaki K; Yoshida M; Matsuoka M; Morishita K; Yuki K; Hanyu A; Miyazawa K; Inazawa J; Miyazono K; Imamura T
J Biol Chem; 2009 Jan; 284(5):3334-3344. PubMed ID: 19049980
[TBL] [Abstract] [Full Text] [Related]
